Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
The HDL handbook : biological functions and clinical implications / / edited by Tsugikazu Komoda
| The HDL handbook : biological functions and clinical implications / / edited by Tsugikazu Komoda |
| Edizione | [Third edition.] |
| Pubbl/distr/stampa | London, England : , : Academic Press, , 2017 |
| Descrizione fisica | 1 online resource (322 pages) : illustrations, tables |
| Disciplina | 572.68 |
| Soggetto topico |
High density lipoproteins - Physiological effect
High density lipoproteins - Metabolism |
| ISBN | 0-12-812514-4 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Molecular mechanisms of hyperalphalipoproteinemia / Shizuya Yamashita, Daisaku Masuda, Tohru Ohama and Masahiro Koseki -- CETP deficiency and concerns in CETP inhibitor development / Akhiro Inazu -- Degenerated HDL and its clinical implications / Hirokazu Honda, Toshiyuki Matsunaga and Tsugikazu Komoda -- HDL Apoprotein mimetic peptides as antiinflammatory molecules / Godfrey S. Getz and Catherine A. Reardon -- Reverse cholesterol transport in HDL metabolism / Maryse Guerin -- Role of ATP-Binding cassette transporters A1 and G1 in reverse cholesterol transport in altherosclerosis / Kazuhiro Nakaya, Makoto Ayaori and Katsunori Ikewaki -- Sphingosin-1-phosphate and HDL metabolism / Xian-Cheng Jiang and Zhiqiang Li -- Role of SR-BI in HDL metabolism / Herbert Stangl and Witta Monika Strobl -- Paroxonase 1 and its clinical relevance / Alejandro Gugliucci -- MicroRNA regulation of HDL homeostasis / Xinghui Sun and Mark W. Feinberg -- The application of proteomic techniques in the study of HDL particle characterization and biomarker discovery / Elena Burillo, Inmaculada Jorge, Diego Martínez-López, Emilio Camafeita, Jesus Vazquez and Jose L. Martin-Ventura -- Therapies targeting HDLc levels and HDL function / Cecelia Vitali and Marina Cuchel. |
| Record Nr. | UNINA-9910583023803321 |
| London, England : , : Academic Press, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
HDL metabolism and diseases / / Lemin Zheng, editor
| HDL metabolism and diseases / / Lemin Zheng, editor |
| Pubbl/distr/stampa | Singapore : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (193 pages) |
| Disciplina | 572.68 |
| Collana | Advances in Experimental Medicine and Biology |
| Soggetto topico |
High density lipoproteins - Metabolism
High density lipoproteins - Metabolism - Disorders |
| ISBN | 9789811915925 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910568273903321 |
| Singapore : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
High-density lipoproteins [[electronic resource] ] : structure, metabolism, function, and therapeutics / / [edited by] Anatol Kontush, M. John Chapman
| High-density lipoproteins [[electronic resource] ] : structure, metabolism, function, and therapeutics / / [edited by] Anatol Kontush, M. John Chapman |
| Pubbl/distr/stampa | Hoboken, N.J., : John Wiley & Sons, Inc., c2012 |
| Descrizione fisica | 1 online resource (650 p.) |
| Disciplina | 572.68 |
| Altri autori (Persone) |
KontushAnatol
ChapmanM. John <1945-> |
| Soggetto topico |
High density lipoproteins - Metabolism
Cardiovascular system - Diseases - Treatment |
| ISBN |
1-283-40110-X
9786613401106 1-118-15867-9 1-118-15866-0 1-118-15864-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
HIGH-DENSITY LIPOPROTEINS; CONTENTS; PREFACE; ACKNOWLEDGMENTS; ABBREVIATIONS; SECTION 1 NORMAL FUNCTIONAL HIGH-DENSITY LIPOPROTEIN; 1 COMPOSITION; 1.1 Proteome; Apolipoproteins; Apolipoprotein A-I; ApoA-II; ApoA-IV; ApoA-V; ApoC-I, ApoC-II, ApoC-III, ApoC-IV; ApoD; ApoE; ApoF; ApoH; ApoJ; ApoL-I; ApoM; Other Apolipoproteins; Enzymes; LCAT; PON1 and PON3; PAF-AH (LpPLA2); GSPx-3; Lipid Transfer Proteins; PLTP; CETP; Acute-Phase Response Proteins; Serum Amyloid A; Other Proteins; Complement Components; Proteinase Inhibitors and Related Proteins; Other Protein Components; 1.2 Lipidome
PhospholipidsSteroids; Cholesteryl Esters; Triglycerides; Minor Lipids; 2 HETEROGENEITY; 2.1 Heterogeneity in Physicochemical Properties; Heterogeneity in Density; Heterogeneity in Electrophoretic Mobility; Heterogeneity in Size; 2.2 Heterogeneity in Chemical Composition; Heterogeneity in Proteins; Heterogeneity in Lipids; 2.3 Relationships Between HDL Subfractions Separated by Different Methods; 3 STRUCTURE; 3.1 Lipid-Free ApoA-I; 3.2 Discoid HDL; 3.3 Spherical HDL; 4 METABOLISM; 4.1 Formation and Intravascular Remodeling; ABC Transporters; ABCA1; ABCG1; Enzymes; LCAT; Lipases Lipid Transfer ProteinsCETP; PLTP; Receptors; SR-BI; 4.2 Catabolism; 5 EPIDEMIOLOGY; 5.1 Epidemiology of HDL-C; HDL-C and Cardiovascular Risk; Relevance Across Multiple Populations and Disease States; HDL-C and Other Cardiovascular Risk Factors; Prevalence of Low HDL-C; HDL-C and Cardiovascular Risk in Patients Receiving Statins; HDL-C and Other Major Diseases; 5.2 Epidemiology of HDL-Associated Proteins and Enzymes; ApoA-I; Other Apolipoproteins; SAA; PON1; PAF-AH; Other Enzymes; Lipid Transfer Proteins; 5.3 Epidemiology of HDL Particle Subpopulations; Separated by Density Separated by Electrophoretic MobilitySeparated by Composition; Separated by Size; 6 GENETICS; 6.1 ABC Transporters and Other Receptors; ABCA1; SR-BI; LDL Receptor; 6.2 Apolipoproteins; ApoA-I; ApoA-V; ApoC-III; ApoE; 6.3 Enzymes; LCAT; PON1; LPL; Hepatic Lipase; Endothelial Lipase; 6.4 Lipid Transfer Proteins; CETP; 6.5 Other Genes; 6.6 Gene Interactions; 7 BIOLOGIC ACTIVITIES; 7.1 Cholesterol Efflux Capacity; Mechanisms of Cellular Cholesterol Efflux; ABCA1-Mediated Efflux; ABCG1-Mediated Efflux; SR-BI-Mediated Efflux; Other Pathways; Role of HDL Components; Proteins; Lipids Functional Heterogeneity of HDL7.2 Antioxidative Activity; Mechanisms of Protection Against Oxidative Stress; Role of HDL Components; Apolipoproteins; Enzymes; Lipids; Functional Heterogeneity of HDL; 7.3 Anti-Inflammatory Activity; Mechanisms of Anti-Inflammatory Protection; Role of HDL Components; Proteome; Lipidome; Functional Heterogeneity of HDL; 7.4 Cytoprotective Activity; Mechanisms of Cytoprotection; Role of HDL Components; Proteome; Lipidome; Functional Heterogeneity of HDL; 7.5 Anti-Infectious Activity; Mechanisms of Protection from Infection; Role of HDL Components; Proteome Lipids |
| Record Nr. | UNINA-9910141177403321 |
| Hoboken, N.J., : John Wiley & Sons, Inc., c2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
High-density lipoproteins : structure, metabolism, function, and therapeutics / / [edited by] Anatol Kontush, M. John Chapman
| High-density lipoproteins : structure, metabolism, function, and therapeutics / / [edited by] Anatol Kontush, M. John Chapman |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Hoboken, N.J., : John Wiley & Sons, Inc., c2012 |
| Descrizione fisica | 1 online resource (650 p.) |
| Disciplina | 572.68 |
| Altri autori (Persone) |
KontushAnatol
ChapmanM. John <1945-> |
| Soggetto topico |
High density lipoproteins - Metabolism
Cardiovascular system - Diseases - Treatment |
| ISBN |
1-283-40110-X
9786613401106 1-118-15867-9 1-118-15866-0 1-118-15864-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
HIGH-DENSITY LIPOPROTEINS; CONTENTS; PREFACE; ACKNOWLEDGMENTS; ABBREVIATIONS; SECTION 1 NORMAL FUNCTIONAL HIGH-DENSITY LIPOPROTEIN; 1 COMPOSITION; 1.1 Proteome; Apolipoproteins; Apolipoprotein A-I; ApoA-II; ApoA-IV; ApoA-V; ApoC-I, ApoC-II, ApoC-III, ApoC-IV; ApoD; ApoE; ApoF; ApoH; ApoJ; ApoL-I; ApoM; Other Apolipoproteins; Enzymes; LCAT; PON1 and PON3; PAF-AH (LpPLA2); GSPx-3; Lipid Transfer Proteins; PLTP; CETP; Acute-Phase Response Proteins; Serum Amyloid A; Other Proteins; Complement Components; Proteinase Inhibitors and Related Proteins; Other Protein Components; 1.2 Lipidome
PhospholipidsSteroids; Cholesteryl Esters; Triglycerides; Minor Lipids; 2 HETEROGENEITY; 2.1 Heterogeneity in Physicochemical Properties; Heterogeneity in Density; Heterogeneity in Electrophoretic Mobility; Heterogeneity in Size; 2.2 Heterogeneity in Chemical Composition; Heterogeneity in Proteins; Heterogeneity in Lipids; 2.3 Relationships Between HDL Subfractions Separated by Different Methods; 3 STRUCTURE; 3.1 Lipid-Free ApoA-I; 3.2 Discoid HDL; 3.3 Spherical HDL; 4 METABOLISM; 4.1 Formation and Intravascular Remodeling; ABC Transporters; ABCA1; ABCG1; Enzymes; LCAT; Lipases Lipid Transfer ProteinsCETP; PLTP; Receptors; SR-BI; 4.2 Catabolism; 5 EPIDEMIOLOGY; 5.1 Epidemiology of HDL-C; HDL-C and Cardiovascular Risk; Relevance Across Multiple Populations and Disease States; HDL-C and Other Cardiovascular Risk Factors; Prevalence of Low HDL-C; HDL-C and Cardiovascular Risk in Patients Receiving Statins; HDL-C and Other Major Diseases; 5.2 Epidemiology of HDL-Associated Proteins and Enzymes; ApoA-I; Other Apolipoproteins; SAA; PON1; PAF-AH; Other Enzymes; Lipid Transfer Proteins; 5.3 Epidemiology of HDL Particle Subpopulations; Separated by Density Separated by Electrophoretic MobilitySeparated by Composition; Separated by Size; 6 GENETICS; 6.1 ABC Transporters and Other Receptors; ABCA1; SR-BI; LDL Receptor; 6.2 Apolipoproteins; ApoA-I; ApoA-V; ApoC-III; ApoE; 6.3 Enzymes; LCAT; PON1; LPL; Hepatic Lipase; Endothelial Lipase; 6.4 Lipid Transfer Proteins; CETP; 6.5 Other Genes; 6.6 Gene Interactions; 7 BIOLOGIC ACTIVITIES; 7.1 Cholesterol Efflux Capacity; Mechanisms of Cellular Cholesterol Efflux; ABCA1-Mediated Efflux; ABCG1-Mediated Efflux; SR-BI-Mediated Efflux; Other Pathways; Role of HDL Components; Proteins; Lipids Functional Heterogeneity of HDL7.2 Antioxidative Activity; Mechanisms of Protection Against Oxidative Stress; Role of HDL Components; Apolipoproteins; Enzymes; Lipids; Functional Heterogeneity of HDL; 7.3 Anti-Inflammatory Activity; Mechanisms of Anti-Inflammatory Protection; Role of HDL Components; Proteome; Lipidome; Functional Heterogeneity of HDL; 7.4 Cytoprotective Activity; Mechanisms of Cytoprotection; Role of HDL Components; Proteome; Lipidome; Functional Heterogeneity of HDL; 7.5 Anti-Infectious Activity; Mechanisms of Protection from Infection; Role of HDL Components; Proteome Lipids |
| Record Nr. | UNINA-9910824325903321 |
| Hoboken, N.J., : John Wiley & Sons, Inc., c2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
